New research shows commercially available artificial tears differ significantly in their viscosity and shear-thinning behaviour, which researchers said may have implications for ocular surface lubrica
Duke Eye Centre researchers said they may have solved a decades-old mystery in ophthalmology, paving the way for a potential treatment of Best vitelliform macular dystrophy, or Best disease. P
Glycated haemoglobin (HbA1c) variability may play an important role in guiding blood glucose control targets in diabetic patients and help predict the progression of adverse renal events or diabetic r
Researchers at Johns Hopkins Medicine say they have advanced understanding of how smoking damages the eye and contributes to the development of age-related macular degeneration (AMD). While it
An Italian study found progression of myopia of prematurity (MOP) was reduced in patients using spectacles with highly aspherical lenslet target (HALT) technology. MOP is a refractive error oc
Authors of a three-year real-world study published by the British Journal of Ophthalmology said repeated low-level red-light (RLRL) therapy showed promising long-term efficacy and safety for myopia co
The optical industry in Australia is building an exciting pipeline of women-led events this year with formats focused on connection and empowerment.
Robbie Williams has linked his worsening vision to the weight-loss injections of “something like Ozempic” he has used for several years, warning readers of The Sun about the potential risks. The singe
Australian & New Zealand Eye Foundation’s (ANZEF’s) grant round 2026 is now open. ANZEF supports initiatives that advance eye health equity and expand access to high-quality ophthalmic care across Aus
Incorporating the world’s first digital binoculars, SeeLuma is a game-changer in ophthalmic surgery, said David Walker, Bausch + Lomb (B+L) ANZ’s surgical marketing manager. “It’s the world’s first fu
Mediworks Scansys Pro 3D anterior segment tomographer offers several key improvements over its predecessor, including crisper imaging, twice the data capture capability and expanded software functiona
Glaukos marked two major 10-year milestones at RANZCO 2025: a decade since it listed on the New York Stock Exchange, and 10 years since vice-president Asia and Glaukos Australasia head Glenn Fawcett e